Andrea Aglitti - Publications

Corrigendum to "Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease".

Journal: Oxidative medicine and cellular longevity

Published: July 13, 2021

Characterisation of asymptomatic patients and efficacy of preventive measures for SARS-CoV-2 infection in a large population of Southern Italy: a cohort study.

Journal: BMJ open

Published: May 11, 2021

Viral hepatitis: Milestones, unresolved issues, and future goals.

Journal: World journal of gastroenterology

Published: February 27, 2021

Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis.

Journal: Metabolomics : Official journal of the Metabolomic Society

Published: July 17, 2020

Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: November 21, 2019

Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice.

Journal: Cancers

Published: October 08, 2019

Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: September 25, 2019

NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome.

Journal: International journal of environmental research and public health

Published: July 31, 2019

HCV point-of-care screening programme and treatment options for people who use drugs in a metropolitan area of Southern Italy.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 15, 2019

Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 26, 2019

Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: August 20, 2018

Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease.

Journal: Oxidative medicine and cellular longevity

Published: March 16, 2018